Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab-Reference-Cited by-同舟云学术

Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab

Published:2010-01-07 Issue:2 Volume:4 Page:150-160
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Prager Gerald W.,Lackner Eva-Maria,Krauth Maria-Theresa,Unseld Matthias,Poettler Marina,Laffer Sylvia,Cerny-Reiterer Sabine,Lamm Wolfgang,Kornek Gabriela V.,Binder Bernd R.,Zielinski Christoph C.,Valent Peter

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2010.01.002/fullpdf

Reference54 articles.

1. Prospective identification of tumorigenic breast cancer cells

2. Tumorigenesis and the angiogenic switch

3. Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma

4. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization

5. Angiogenesis in cancer and other diseases

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant pleural disease;Breathe;2023-12

2. Targeting endothelial permeability in the EPR effect;Journal of Controlled Release;2023-09

3. Malignant Pleural Effusions in the Era of Immunotherapy and Antiangiogenic Therapy;Seminars in Respiratory and Critical Care Medicine;2023-06-12

4. Growth Factors and Cancer;Molecular Targets and Cancer Therapeutics (Part 1);2023-04-18

5. Phase I trial of single-agent recombinant human anti-vascular endothelial growth factor (GB222) followed a combination therapy of GB222 and temozolomide in patients with recurrent WHO grade III and IV glioma;Current Medicine;2022-07-04